SCOPUS 정보 검색 플랫폼

Volumn 92, Issue 5, 2013, Pages 711-713

Splenectomy followed by administration of rituximab is useful to treat a patient with hairy cell leukemia-variant

(7) Yoshida, Tetsumi a Mihara, Keichiro a Sugihara, Sayaka a Arihiro, Koji a Mino, Tatsuji a Sasaki, Naomi b Takihara, Yoshihiro a

a HIROSHIMA UNIVERSITY (Japan)

b Kure Kyosai Hospital (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

RITUXIMAB;

ABDOMINAL MASS; AGED; B LYMPHOCYTE; CASE REPORT; CHROMOSOME 14; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; FEMALE; GENE REARRANGEMENT; HAIRY CELL LEUKEMIA; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN HEAVY CHAIN GENE; KARYOTYPE; LETTER; LYMPHOCYTE; MULTIPLE CYCLE TREATMENT; PANCYTOPENIA; PRIORITY JOURNAL; SPLENECTOMY; SPLENOMEGALY; THROMBOCYTE COUNT;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; LEUKEMIA, HAIRY CELL; SPLENECTOMY; TREATMENT OUTCOME;

EID: 84877922289 PISSN: 09395555 EISSN: 14320584 Source Type: Journal
DOI: 10.1007/s00277-012-1612-1 Document Type: Letter

Times cited : (9)

References (7)

1
- 53249123632
- 4 International Agency for Research on Cancer Lyon
- Swerdlow SH, Campo E, Harris NL et al (2008) WHO classification of tumours of haematopoietic and lymphoid tissues, 4th edn. International Agency for Research on Cancer, Lyon
- (2008) WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
- Swerdlow, S.H.¹ Campo, E.² Harris, N.L.³

2
- 84863835270
- The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma
- 22594855 10.1111/j.1365-2141.2012.09163.x 1:CAS:528:DC%2BC38XhtFKls7nN
- Hockley SL, Else M, Morilla A et al (2012) The prognostic impact of clinical and molecular features in hairy cell leukaemia variant and splenic marginal zone lymphoma. Br J Haematol 158:347-354
- (2012) Br J Haematol , vol.158 , pp. 347-354
- Hockley, S.L.¹ Else, M.² Morilla, A.³

3
- 78649893951
- Hairy-cell leukemia variant: Recent view on diagnosis, biology and treatment
- 20558005 10.1016/j.ctrv.2010.05.003
- Robak T (2011) Hairy-cell leukemia variant: recent view on diagnosis, biology and treatment. Cancer Treat Rev 37:3-10
- (2011) Cancer Treat Rev , vol.37 , pp. 3-10
- Robak, T.¹

4
- 84155194988
- Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant
- 22111844 10.1111/j.1365-2141.2011.08931.x
- Jones G, Parry-Jones N, Wilkins B et al (2011) Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant. Br J Haematol 156:186-195
- (2011) Br J Haematol , vol.156 , pp. 186-195
- Jones, G.¹ Parry-Jones, N.² Wilkins, B.³

5
- 23144445811
- Successful treatment of hairy cell leukemia variant with rituximab
- 16085567 10.1080/10428190500083433 1:CAS:528:DC%2BD2MXpslyjsLs%3D
- Narat S, Gandla J, Dogan A, Mehta A (2005) Successful treatment of hairy cell leukemia variant with rituximab. Leuk Lymphoma 46:1229-1232
- (2005) Leuk Lymphoma , vol.46 , pp. 1229-1232
- Narat, S.¹ Gandla, J.² Dogan, A.³ Mehta, A.⁴

6
- 33744998473
- Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab
- Quach H, Januszewicz H, Westerman D (2005) Complete remission of hairy cell leukemia variant (HCL-v) complicated by red cell aplasia post treatment with rituximab. Haematologica 90:e72-e73
- (2005) Haematologica , vol.90
- Quach, H.¹ Januszewicz, H.² Westerman, D.³

7
- 74949122021
- How i treat hairy cell leukemia
- 19843881 10.1182/blood-2009-06-195370 1:CAS:528:DC%2BC3cXnvVOqug%3D%3D
- Grever MR (2010) How I treat hairy cell leukemia. Blood 115:21-28
- (2010) Blood , vol.115 , pp. 21-28
- Grever, M.R.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.